1.A case report of TAFRO syndrome.
Guang Ping ZHOU ; Qian Yun ZHOU ; Ji Hong ZHU
Journal of Peking University(Health Sciences) 2021;53(4):814-817
The study is to improve clinicians' understanding of TAFRO syndrome, to explore the diagnosis and treatment of TAFRO syndrome and to identify TAFRO syndrome in the early stage. The clinical manifestations, laboratory examination results, imaging manifestations, diagnosis and treatment of TAFRO syndrome were reported, and the literature of TAFRO syndrome was reviewed. The main clinical manifestations of the female were intermittent vaginal bleeding, fever, depressive edema of both legs, red blood cell and thrombocytopenia, and renal function deterioration. The results showed that leukocytes increased, anemia, thrombocytopenia and severe renal dysfunction were found; With fever, C-reactive protein and procalcitonin increased significantly, bone penetration suggested that granulocyte proliferation was active, and megakaryocytes were seen. But anti-infection treatment was ineffective; CT suggested that there was a high uptake of multiple fluorodeoxyglucose (FDG) in many parts of the body; The lymph node biopsy was considered to be in accordance with the transparent vascular type of Castleman disease; Renal biopsy was used to return thrombotic microvascular disease with subacute renal tubulointerstitial nephropathy. In terms of treatment, the clinical condition of the patients was improved after methylprednisolone (60 mg, once a day), the temperature was normal, and the effusion in the serous cavity was better than before. The blood transfusion and platelet support therapy were intermittently given. Hemoglobin and platelets were increased in sex, and the urine volume increased to 1 000 mL/day. However, the platelet dropped at a later time, after 1 month of treatment with topizumab, the clinical condition of the patients was further improved. At present, the blood pigment and platelets returned to normal and had been separated from dialysis. TAFRO syndrome is a special subtype of idiopathic multicentric Castleman disease, and it is a group of systemic inflammatory diseases with its own characteristics. Its clinical manifestations and diagnosis and treatment are unique compared with other idiopathic multicentric Castleman diseases. For the enlargement of lymph nodes of unknown reasons, it is suggested to improve the lymph node biopsy actively. Renal insufficiency is an important part of TAFRO syndrome. Renal biopsy is of great significance to study the pathogenesis of TAFRO syndrome and to judge the prognosis of patients. The clinical diagnosis of the disease requires comprehensive clinical manifestations and the results of various examinations. Early diagnosis and early treatment of the disease can often achieve good clinical effect.
Castleman Disease
;
Edema
;
Female
;
Fever/etiology*
;
Humans
;
Kidney
;
Renal Insufficiency
2.A biomarker, osteoprotegerin, in patients undergoing hemodialysis.
The Korean Journal of Internal Medicine 2013;28(6):654-656
No abstract available.
Cardiovascular Diseases/*etiology
;
Female
;
Humans
;
Male
;
Osteoprotegerin/*blood
;
*Renal Dialysis
;
Renal Insufficiency, Chronic/*therapy
;
*Vascular Stiffness
5.Inadvertent haemodialysis in a pulmonary tuberculosis patient with hypercalcaemia.
Chai Soon NGIU ; Chee Yean LOO ; Andrea Y L BAN ;
Annals of the Academy of Medicine, Singapore 2010;39(5):415-416
Cachexia
;
etiology
;
Cough
;
Delayed Diagnosis
;
Fever
;
Humans
;
Hypercalcemia
;
etiology
;
Male
;
Middle Aged
;
Radiography
;
Renal Dialysis
;
Renal Insufficiency
;
etiology
;
therapy
;
Tuberculosis, Pulmonary
;
complications
;
diagnostic imaging
6.Risk of Chronic Kidney Disease After Nephrectomy for Renal Cell Carcinoma.
Korean Journal of Urology 2014;55(10):636-642
The incidence of low-stage renal cell carcinoma is rising and is observed to demonstrate excellent prognosis following surgical treatment irrespective of method. However, several epidemiologic observational and population-based studies suggest that radical nephrectomy is associated with increased adverse renal outcomes such as chronic kidney disease (CKD) compared with partial nephrectomy. This is suggested in turn to lead to increased mortality via an increase in cardiovascular complications and mortality. Prospective data are scarce, and there are conflicting data as well on whether surgically induced CKD is as debilitating as medically induced CKD. Further research is needed to assess the presence and the extent of the relationship between nephrectomy, CKD, and noncancer mortality.
Carcinoma, Renal Cell/*surgery
;
Humans
;
Kidney Neoplasms/*surgery
;
Nephrectomy/*adverse effects/methods
;
Renal Insufficiency, Chronic/epidemiology/*etiology
;
Risk Assessment/methods
7.The Optimal Revascularization Therapy for Coronary Artery Disease Patients with Chronic Kidney Disease.
The Korean Journal of Internal Medicine 2012;27(4):388-390
No abstract available.
*Drug-Eluting Stents
;
Female
;
Humans
;
Male
;
Myocardial Infarction/*etiology/*therapy
;
Renal Insufficiency, Chronic/*complications
9.Etiological analysis of 264 cases with chronic kidney disease stage 2 to 5 in children.
Qianfan MIAO ; Qian SHEN ; Hong XU ; Li SUN ; Xiaoshan TANG ; Xiaoyan FANG ; Haimei LIU ; Yihui ZHAI ; Yunli BI ; Xiang WANG ; Hong CHEN
Chinese Journal of Pediatrics 2015;53(9):665-669
OBJECTIVETo study and summarize the etiology of children patients with chronic kidney disease (CKD) stage 2 to 5 seen in Children's Hospital of Fudan University from Jan. 2004 to Dec. 2013.
METHODBy complying with the NKF-K/DOQI guidelines, we collected data of 264 cases of children patients with CKD stage 2-5 from Jan. 2004 to Dec. 2013 in the medical record system of Children's Hospital of Fudan University. And we retrospectively analyzed their age and CKD stage at first diagnosis, primary diseases, complications, etc.
RESULTIn the collected 264 cases, 52 cases (19.7%) were diagnosed at stage 2, 67 (25.4%) at stage 3, 52 (19.7%) at stage 4 and 93 (35.2%) at stage 5. For disease causes, 116 cases (43.9%) had congenital anomalies of the kidney and urinary tract (CAKUT), 61 cases (23.1%) had glomerular disease, 15 (5.7%) had hereditary kidney disease, 14 (5.3%) had other diseases and in 58 cases (22.0%) the causes of disease were unknown. In the group with age between 0 and 3.0 and 3.1 and 6.0 years, 57.1% (24 cases) and 60.0% (30 cases) had primary disease with CAKUT. In the group with age older than 10 years, 49.2% (30 cases) had primary disease with glomerular disease and 32.0% (32 cases) with unknown causes.
CONCLUSIONThe major cause of CKD stage 2-5 in children in our hospital during the last ten years was CAKUT (43.9%), followed by glomerular disease (23.1%). The primary diseases of CKD were significantly different between the 2 age groups. CAKUT was more common in infants and preschool children while for adolescents, glomerular disease was the major cause.
Child ; Child, Preschool ; China ; Humans ; Infant ; Infant, Newborn ; Kidney ; physiopathology ; Renal Insufficiency, Chronic ; etiology ; Retrospective Studies
10.New Goals and Strategies of Chinese Medicine in Prevention and Treatment of Chronic Kidney Disease.
Chuan GUO ; Shen LI ; Xiang-Rong RAO
Chinese journal of integrative medicine 2019;25(3):163-167
Chronic kidney disease (CKD) is a clinical syndrome with a series of clinical manifestations and metabolic disorders caused by many diseases, which are characterized by progressive deterioration or irreversible damage of renal structures and functions. With the progress of epidemiological research, CKD has brought about huge economic and psychological burdens. There is a considerable risk of cardiovascular events or death than progression to end-stage renal disease for patients. Particular attentions should be paid to the new goals of reducing cardiovascular events and all-cause mortality. It is important to analyze the etiology and pathogenesis according to patients' ages, regions, primary disease as well as different stages of disease, and choose the appropriate therapeutic strategies accordingly. In clinical practice, due to the uncertainty of therapeutic effects of modern medicine based on the risk factors, it is necessary to use Chinese medicine (CM) to delay the disease progression and reduce comorbidities. Turbid toxin and blood stasis are two critical pathological factors worthy of concerns in the theory of CM. In addition, appropriate use of CM may help improve the quality of life of patients with CKD.
Hemostasis
;
Humans
;
Medicine, Chinese Traditional
;
Renal Insufficiency, Chronic
;
blood
;
drug therapy
;
etiology
;
prevention & control